REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim Korea Ltd. (South Korea)

Main Activities: Chemical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boehringer Ingelheim Korea Ltd. Profile Updated: December 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Boehringer Ingelheim Korea Ltd. is a company in South Korea, with a head office in Seoul. The enterprise operates in the Chemical Manufacturing industry. The company was established on March 03, 1976. 164 (2024) employees currently work for Boehringer Ingelheim Korea Ltd.. In 2023, the company reported a net sales revenue increase of 6.97%. Over the same period, its total assets grew by 22.7%. The net profit margin of Boehringer Ingelheim Korea Ltd. increased by 2.5% in 2023.

Headquarters
16th Floor, 10, Tongil-ro Jung-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Boehringer Ingelheim Korea Ltd. report to view the information.

Website: http://www.bikr.co.kr

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim Korea Ltd. report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim Korea Ltd. report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim Korea Ltd. report to view the information.
Incorporation Date:
March 03, 1976
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Boehringer Ingelheim Animal Health Korea Ltd.
Company Performance
Financial values in the chart are available after Boehringer Ingelheim Korea Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.97%
Total operating revenue
6.97%
Operating profit (EBIT)
-49.24%
EBITDA
-43.21%
Net Profit (Loss) for the Period
108.77%
Total assets
22.7%
Total equity
13.71%
Operating Profit Margin (ROS)
-2.03%
Net Profit Margin
2.5%
Return on Equity (ROE)
19.7%
Debt to Equity Ratio
39.71%
Quick Ratio
0.01%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?